Search

Recent news

Amprologix engages corporate finance partners FRP for its…

We are delighted to be working with Adrian Gare and Alex Starling at FRP, who have a great track record…

Amprologix moves into new offices at Plymouth Science…

Having been based in the Marine Building at Plymouth University for the last 2-years, the company is now moving to…

Understanding the mode of action of lead candidate

Amprologix CSO collaborates with Dr Max Ryadnov from the UK’s National Physical Laboratory, to publish new data on the novel…

News categories

News articles

2 December 2020
Amprologix engages corporate finance partners FRP for its seed and series-A investment rounds

We are delighted to be working with Adrian Gare and Alex Starling at FRP, who have a great track record in early stage financing and bring a wealth of life science sector experience to the team.

Read More
2 December 2020
Amprologix moves into new offices at Plymouth Science Park

Having been based in the Marine Building at Plymouth University for the last 2-years, the company is now moving to the Derriford Research Facility to accommodate our expansion plans as we transition into the clinical phase of our antibiotic discovery programmes.

Read More
21 August 2020
Understanding the mode of action of lead candidate

Amprologix CSO collaborates with Dr Max Ryadnov from the UK’s National Physical Laboratory, to publish new data on the novel mode of action of epidermicin NI01. Findings are reported in the August issue of iScience.

Read More
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram